Cheng, Y., Wu, L., Parsonson, A., Amin, H., Shi, J., Lemech, C., . . . Lisberg, A. (2024). 57O A phase I/II multicenter, first-in-human study of DB-1311/BNT324 (a novel B7H3 ADC) in patients with advanced solid tumors. Annals of Oncology, 35, S1426. https://doi.org/10.1016/j.annonc.2024.10.078
Chicago Style (17th ed.) CitationCheng, Y., et al. "57O A Phase I/II Multicenter, First-in-human Study of DB-1311/BNT324 (a Novel B7H3 ADC) in Patients with Advanced Solid Tumors." Annals of Oncology 35 (2024): S1426. https://doi.org/10.1016/j.annonc.2024.10.078.
MLA (9th ed.) CitationCheng, Y., et al. "57O A Phase I/II Multicenter, First-in-human Study of DB-1311/BNT324 (a Novel B7H3 ADC) in Patients with Advanced Solid Tumors." Annals of Oncology, vol. 35, 2024, p. S1426, https://doi.org/10.1016/j.annonc.2024.10.078.